All of our forecasts are generated from our proprietary forecasting system that leverages our vast amount of neighborhood weather data that we get from our community - we refer to the system as ...

Sanofi says that its experimental drug amlitelimab has the potential to become a ‘best-in-class’ maintenance therapy for atopic dermatitis (AD) after reporting new phase 2b data. The latest ...